News
Important Only
Brazil and US are negotiating terms of understanding on tariffs, says Brazilian Finance Minister
SAO PAULO, May 5 (Reuters) - Brazilian Finance Minister Fernando Haddad said Brazil and the U.S. are negotiating the terms of an understanding on tariffs. Haddad said on Sunday that he spoke to U.S. Treasury Secretary Scott Bessent "on behalf of the region," since according to him, it doesn&...Reuters
Mon, May 5
Arrivent Biopharma Inc expected to post a loss of 66 cents a share - Earnings Preview
Arrivent Biopharma Inc AVBP.OQ AVBP.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Arrivent Biopharma Inc is for a loss of 66 cents per share. The current average analyst rati...Reuters
Mon, May 5
Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview
Clearside Biomedical Inc CLSD.OQ CLSD.O is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Alpharetta Georgia-based company is expected to report a 26.1% decrease in revenue to $170 thousand from $230 thousand a year ...Reuters
Mon, May 5
Phunware Inc expected to post a loss of 12 cents a share - Earnings Preview
Phunware Inc PHUN.OQ PHUN.O is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Austin Texas-based company is expected to report a 26.7% decrease in revenue to $674.75 thousand from $921 thousand a year ago, according ...Reuters
Mon, May 5
ALX Oncology Holdings Inc expected to post a loss of 46 cents a share - Earnings Preview
ALX Oncology Holdings Inc ALXO.OQ ALXO.O is expected to show no change in quarterly revenue when it reports results on May 8 for the period ending March 31 2025LSEG's mean analyst estimate for ALX Oncology Holdings Inc is for a loss of 46 cents per share. The current average analyst rating on ...Reuters
Mon, May 5
Morning News Call - U.S., May 5
To access a PDF version of this newsletter, please click hereYou can read Morning News Call -- US via TOPNEWS U.S. Companies page.If you would like to receive this newsletter through your email, please register at:https://solutions.lseg.com/MorningNewsCallEN-subscription-pageFor Morning News Call Ca...Reuters
Mon, May 5
Atara Biotherapeutics Inc expected to post a loss of $1.98 a share - Earnings Preview
Atara Biotherapeutics Inc ATRA.OQ ATRA.O is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Thousand Oaks California-based company is expected to report a 79.3% decrease in revenue to $5.667 million from $27.36 millio...Reuters
Mon, May 5
Skillz Inc expected to post a loss of $1.09 a share - Earnings Preview
Skillz Inc SKLZ.N, SKLZ.K is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Las Vegas Nevada-based company is expected to report a 17.8% decrease in revenue to $20.752 million from $25.24 million a year ago, accordin...Reuters
Mon, May 5
INmune Bio Inc expected to post a loss of 47 cents a share - Earnings Preview
INmune Bio Inc INMB.OQ INMB.O is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for INmune Bio Inc is for a loss of 47 cents per share. The current average analyst rating on the shares is...Reuters
Mon, May 5
Gyre Therapeutics Inc expected to post earnings of 3 cents a share - Earnings Preview
Gyre Therapeutics Inc GYRE.OQ GYRE.O is expected to report resultson May 7 (estimated) for the period ending March 31 2025The San Diego California-based company is expected to report revenue of $28.4 million, according to the estimate from one analyst, based on LSEG data.LSEG's mean analyst es...Reuters
Mon, May 5
Tempest Therapeutics Inc expected to post a loss of $3.29 a share - Earnings Preview
Tempest Therapeutics Inc TPST.OQ TPST.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Tempest Therapeutics Inc is for a loss of $3.29 per share. The current average analyst rat...Reuters
Mon, May 5
MacroGenics Inc expected to post a loss of 78 cents a share - Earnings Preview
MacroGenics Inc MGNX.OQ MGNX.O is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Rockville Maryland-based company is expected to report a 32.3% decrease in revenue to $6.167 million from $9.1 million a year ago, acco...Reuters
Mon, May 5
Romania PM under pressure after far-right wins first-round of president vote
Far-right leader Simion wins presidential ballot first-roundHe will face centrist mayor in May 18 run-offRomania leftist PM Ciolacu under pressure to resignRomanian debt yields jump By Luiza Ilie and Elizaveta Gladun BUCHAREST, May 5 (Reuters) - Romania's Social Democrat Prime Minister Marcel...Reuters
Mon, May 5
Vor Biopharma Inc expected to post a loss of 25 cents a share - Earnings Preview
Vor Biopharma Inc VOR.OQ VOR.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Vor Biopharma Inc is for a loss of 25 cents per share. The current average analyst rating on the sh...Reuters
Mon, May 5
EU's Ribera: Microsoft Chairman says his company will abide by EU rules
BARCELONA, May 5 (Reuters) - Microsoft MSFT.O Chairman Brad Smith has told the European Commission his company will abide by European rules whether it agrees or not with them, the Commission's Vice President Teresa Ribera said on Monday.The U.S. tech giant said last month it would sell its chat ...Reuters
Mon, May 5
Adverum Biotechnologies Inc expected to post a loss of $1.94 a share - Earnings Preview
Adverum Biotechnologies Inc ADVM.OQ ADVM.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Adverum Biotechnologies Inc is for a loss of $1.94 per share. The current average analy...Reuters
Mon, May 5
Achieve Life Sciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Achieve Life Sciences Inc is for a loss of 36 cents per share. The current average analys...Reuters
Mon, May 5
4D Molecular Therapeutics Inc expected to post a loss of 86 cents a share - Earnings Preview
4D Molecular Therapeutics Inc FDMT.OQ FDMT.O is expected to show a rise in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Emeryville California-based company is expected to report a 1,266.3% increase in revenue to $382.57 thousand from $28 tho...Reuters
Mon, May 5
Astria Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview
Astria Therapeutics Inc ATXS.OQ ATXS.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Astria Therapeutics Inc is for a loss of 48 cents per share. The current average analyst ra...Reuters
Mon, May 5
